NCT00880919 - Seroquel Extended Release (XR) for the Management of Borderline Personality Disorder (BPD) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions

Borderline Personality Disorder

Interventions

DRUG

quetiapine extended-release

Seroquel XR 150mg/day vs Seroquel XR 300mg/day vs Placebo

DRUG

Placebo

Seroquel XR 150mg/day vs Seroquel XR 300mg/day vs Placebo

Trial Locations (3)

University of Iowa, Department of Psychiatry, Iowa City

University of Minnesota Medical Center, Fairview Riverside, Minneapolis

McLean Hospital, Harvard Medical School, Department of Psychiatry, Belmont